3.495USD+3.40%Mkt Cap: 1.09B USDP/E: —Last update: 2026-05-26
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, …
Industry Peers
Biotechnology110.61BUSDP/E 25.8
106.49BDKKP/E 20.5
66.47BUSDP/E 15.5
46.51BEURP/E 30.5
43.17BEURP/E 35.9
39.41BUSDP/E 74.0
32.84BUSD—
31.18BSEKP/E 46.1
Indicators:|
Key Statistics
Company
Market Cap1.09B USD
Enterprise Value1.32B USD
Revenue (TTM)360.78M USD
Gross Profit261.01M USD
Net Income (TTM)5.86M USD
Revenue/Share1.309 USD
Last Price3.495 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees591
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS56400P7069
Valuation
P/E (Trailing)—
P/E (Forward)17.19
PEG4.39
EV/EBITDA37.45
EV/Revenue3.67
P/S2.83
P/B-17.24
EPS (TTM)-0.07
EPS (Forward)0.19
52W Range
2.23030% of range6.510
52W High6.510 USD
52W Low2.230 USD
Profitability
Gross Margin74.79%
Oper. Margin-3.31%
EBITDA Margin9.79%
Profit Margin1.68%
ROE-11.49%
ROA0.74%
Growth
Revenue Growth15.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF18.25M USD
CapEx (TTM)4.57M USD
FCF Margin13.03%
FCF Yield4.32%
Net Debt300.29M USD
Net Debt/EBITDA8.50
Balance Sheet
Debt/Equity-7.20
Current Ratio1.87
Quick Ratio1.43
Book Value/Sh-0.1920 USD
Cash/Share0.4330 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay DateMar 3, 2017
Splits
Last Split1:5
Split DateMar 3, 2017
Analyst Consensus
Rating1.3 (Strong Buy)
Target (Mean)7.469 USD
Target Range4.750 USD – 10.00 USD
# Analysts8
Ownership
Shares Out.308.95M
Float304.28M
Insiders1.53%
Institutions59.28%
Short Interest
Short Ratio8.0d
Short % Float9.76%
Short % Out.9.62%
Shares Short29.73M
Short (prev mo.)29.46M
Technical
SMA 502.787 (+25.4%)
SMA 2004.568 (-23.5%)
Beta1.04
S&P 52W Chg28.31%
Avg Vol (30d)5.70M
Avg Vol (10d)5.35M
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—